Specific mechanistic aspects of animal tumor promoters: the okadaic acid pathway.
Fujiki
H
H
Cancer Prevention Division, National Cancer Center Research Institute, Tokyo, Japan.
Suganuma
M
M
Nishiwaki
S
S
Yoshizawa
S
S
Yatsunami
J
J
Matsushima
R
R
Furuya
H
H
Okabe
S
S
Matsunaga
S
S
Sugimura
T
T
D000818:Animals; D000935:Antifungal Agents / Q000633:toxicity; D002273:Carcinogens / Q000633:toxicity*; D004988:Ethers, Cyclic / Q000633:toxicity*; D008113:Liver Neoplasms / Q000139:chemically induced* / Q000473:pathology; D008387:Marine Toxins; D051379:Mice; D015394:Molecular Structure; D019319:Okadaic Acid; D010080:Oxazoles / Q000633:toxicity; D010456:Peptides, Cyclic / Q000633:toxicity; D011714:Pyrans; D051381:Rats; D012878:Skin Neoplasms / Q000139:chemically induced* / Q000473:pathology; D013141:Spiro Compounds / Q000633:toxicity; D013274:Stomach Neoplasms / Q000139:chemically induced* / Q000473:pathology; D013329:Structure-Activity Relationship
D000935:Antifungal Agents; D002273:Carcinogens; D004988:Ethers, Cyclic; D008387:Marine Toxins; D010080:Oxazoles; D010456:Peptides, Cyclic; D011714:Pyrans; D013141:Spiro Compounds; C063998:nodularin; C053079:tautomycin; D019319:Okadaic Acid; C065560:acanthifolicin; C059041:calyculin A